Skye Bioscience (SKYE) Change in Receivables (2013 - 2014)
Skye Bioscience (SKYE) posted quarterly Change in Receivables of $10087.0 for Q2 2014, down 3.44% year-over-year from $10446.0 in Q2 2013, and up 403.09% quarter-over-quarter from -$3328.0 in Q4 2013.
Skye Bioscience (SKYE) Change in Receivables (2013 - 2014) Analysis & Trends
Skye Bioscience (SKYE) has reported Change in Receivables for 2 consecutive years, with $10087.0 the latest figure, recorded in Q2 2014.
- In Q2 2014, Change in Receivables fell 3.44% year-over-year to $10087.0; the TTM figure through Apr 2014 stood at $13793.0 (changed N/A YoY), while the FY2013 annual figure was $18432.0, up 166.9% from the prior year.
- Change in Receivables rose to $10087.0 in Q2 2014 per SKYE's latest filing, from -$3328.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $14726.0 in Q1 2013 and bottomed at -$3412.0 in Q3 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -53.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 117.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 31.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 94.29 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 37.16 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Skye Bioscience | 10.86 Mn | 10.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2014 | 10,087.00 |
| Apr 30, 2014 | 10,087.00 |
| Oct 31, 2013 | -3,328.00 |
| Oct 31, 2013 | -3,328.00 |
| Jul 31, 2013 | -3,412.00 |
| Jul 31, 2013 | -3,412.00 |
| Apr 30, 2013 | 10,446.00 |
| Apr 30, 2013 | 10,446.00 |
| Jan 31, 2013 | 14,726.00 |
| Jan 31, 2013 | 14,726.00 |